known

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis in

Embracing the True Spirit of Decentralization: Shiba Classic – Your New Haven!

The idea of decentralization has taken front stage in the fast-paced world of cryptocurrencies, promising a more equitable, inclusive, and transparent financial environment. Not all projects, nevertheless, have adhered to these guidelines. Enter Shiba Classic (SHIBC), a game-changer with a team that has a track record of success taking projects from $0 to $100 million. Shiba Classic is an example of what decentralization stands for. The Shiba Classic crew is now all in and prepared to cause a stir in the DeFi community. Unveiling Shiba Classic - A True Beacon

Zero-G Racetrack Rides into New Territory with Electro-Western Anthem “Never Ride Alone”

[Silicon Valley, October 6, 2023] - Zero-G Racetrack, Silicon Valley’s up and coming Electronic Rock artists, are back with their latest single, "Never Ride Alone”, seamlessly combining the storytelling of classic country western legends with the retro-future allure of Electronic Rock. Zero-G Racetrack has been gaining recognition for their unique approach of using various genre callbacks within the context of electronic dance music. With “Never Ride Alone”, Zero-G Racetrack tips their hat to the compelling Western tales spun by legends like Johnny Cash and Waylon Jennings, setting out to bring

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

Starbox Group’s StarboxAI – ViPro Module: Transforming Content Creation

Kuala Lumpur, Malaysia, Sept 5th, 2023 – Starbox Group Holdings Ltd. (Nasdaq: STBX), a dynamic player in cash rebates, digital advertising, and payment solutions, with a vision of leading in artificial intelligence (“AI”) solutions throughout Southeast Asia, is making waves with the launch of its groundbreaking StarboxAI - ViPro module. This innovative module introduces a text-to-video feature set to redefine content creation. The Text-to-Video feature within the StarboxAI - ViPro module is not just an addition; it's a revelation. It empowers content creators to seamlessly transmute textual instructions or scripts

Starbox Group Holdings Ltd. Announces First Half of Fiscal Year 2023 Financial Results

Revenue and Net Profit Increased with Technology Driven Services Revenue Accounted for Approximately 43.8% of its Revenue KUALA LUMPUR, Malaysia, August 29, 2023 / Plato / Amplifi. Starbox Group Holdings Ltd. (Nasdaq: STBX) ("Starbox" or "the Company”), a service provider of cash rebates, digital advertising, and payment solutions with a goal of becoming a comprehensive AI solutions provider within Southeast Asia, today announced its unaudited financial results for the six months ended March 31, 2023. Mr. Lee Choon Wooi, Chairman and Chief Executive Officer of Starbox, commented, “We are excited

Swiss WEB3FEST 2023: The Convergence of Web3 Innovation and Collaboration

The Global Web3 Ecosystem is set to unite under the banner of "Switzerland United", an 11-day extravaganza, from September 7th-17th 2023, that combines the forces of the NFT Fest Lugano, NFT Lakeside Unconference and the Swiss WEB3FEST. Key Highlights The Swiss WEB3FEST will be the center of Web3 innovation and collaboration, with over 150 Preeminent speakers, 50+ exhibitors and 80+ captivating topics and side events The Swiss WEB3FEST is the Ecosystem Festival of Crypto Valley and Crypto Oasis and is Co-Hosted by Dfinity aka The Internet Computer The Conference is

Clockout Breaks New Ground in Wage Access. Launches and Expands its Reach to 42 States

Historically, on-demand wage access required significant backend adjustments, coordination and often posed integration hurdles for employers. Clockout, a cutting-edge fintech platform, is pushing the boundaries of the traditional earned wage access model. In a bold move to address common industry challenges, the company has unveiled a streamlined, implementation-free model for employers, eliminating the need for cumbersome contracts and implementations and making offering their workforce immediate access to earned wages effortless. Clockout amplifies businesses' employee motivation, retention, and hiring leverage; while placing the power directly in the hands of the employees

Ex-Singapore Parliamentarian’s Swiss Company Launches Swiss Franc and Euro Stablecoins

Singapore investor and former parliamentarian Calvin Cheng's newly rebranded Swiss company, Anchored Coins, was granted membership in the Swiss VQF in early 2023. VQF is the largest and oldest cross-industry self-regulatory organisation in Switzerland and is officially recognised by FINMA, the country's financial services watchdog. Anchored Coins is launching a Swiss Franc-backed stablecoin (ACHF) and a Euro-backed stablecoin (AEUR), and will be issued on the Ethereum and BNB Chain blockchains. DCS Card Centre in Singapore is planning to issue credit cards collateralised by AEUR and ACHF. ZURICH, SWITZERLAND, Aug 16,

SCCG Partners with Kajot Games for Distribution of iGaming Content to North America and Worldwide

Las Vegas, NV – SCCG Management, a leading advisory firm in the global gambling industry, is excited to announce a strategic partnership with Kajot, for the distribution of their world-class iGaming content, with an initial focus on social gaming in the United States. The collaboration is poised to eventually expand into real-money gaming within the US market, including targeted initiatives within specific states in collaboration with tribal casinos. Stephen Crystal, Founder & CEO of SCCG, stated, “We are thrilled to join forces with Kajot, an innovative partner known for their

BREATHE! Convention Charts New Territory with World’s Largest Communal NFT

For Immediate Release June 19, 2023 LAS VEGAS, NV - BREATHE! Convention, a leading event in the emerging tech space, proudly announces a groundbreaking endeavor to set a new Guinness World Record with the creation of the World’s Largest Communal NFT, during its upcoming convention in Las Vegas from September 13 to 15, 2023. At the heart of this year's convention is a monumental collaborative art project spearheaded by tech industry veteran and creative thinker, Aaron Vick. Known for his innovative digital art pieces, Aaron Vick will facilitate the creation

Coya Therapeutics Reports Additional Biomarker and Imaging Data Showing Decrease in Neuroinflammation with COYA 301 in Alzheimer’s Disease.

Highlights Coya reports new data illustrating that administration of COYA 301 (low dose Interleukin-2 (IL-2)) in an open- label study in 8 patients with mild to moderate AD (COYA 301 Trial) resulted in a statistically significant reduction in the expression of three well characterized proinflammatory cytokines -- Tumor Necrosis Factor alpha (TNF-α), Interleukin 6 (IL-6), and Interleukin 1- Beta (IL-1β) -- which correlated with lack of cognitive decline of the patients over the course of the study. TNF-α is one of the main inflammatory cytokines involved in initiating and propagating